June 2016 FDA Recall Drug by Hospira Inc.
D-0169-2017 - Failed Stability Specifications

This Class III drug recall was voluntarily initiated by Hospira Inc. on June 29, 2016 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed in US and Puerto Rico and the recall is currently terminated.

Recall Number: D-0169-2017

Reason for Recall
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Initiated
06-29-2016
Reported
12-14-2016
Quantity
287,200 2 mL ampules

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
US and Puerto Rico
5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Batch or Lot Expiration Information

Lot# 34-547-DK, 34-548-DK, Exp. 10/16
Lot# 39-372-DK, Exp. 03/17 Lot Number may be followed by numbers from 01 to 99